Delirium, Dementia, Alcohol Intoxication, and Withdrawal Syndromes

  • Hoyle Leigh

A 72-year-old man with a long-standing diagnosis of schizophrenia living in a board and care home was brought to the hospital by the police because of altered mental state and agitation. The patient was combative both in the ambulance and in the emergency department (ED). He was prescribed lorazepam 1 mg IM in the ED, but the agitation did not subside. The patient was noted to be disoriented to time and place. He attempted to hit the nursing staff, and thus was placed in leather restraints. The patient continued screaming obscenities. He then received 2 mg of haloperidol IM and an additional 2 mg of lorazepam, which made him somnolent. Laboratory findings indicated the presence of a urinary tract infection.


Vascular Dementia Withdrawal Syndrome Alcohol Withdrawal Alcohol Intoxication Extrapyramidal Side Effect 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Breitbart W, Marotta R, Platt MM, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153(2):231–237.PubMedGoogle Scholar
  2. Brun A, Englund B, Gustafson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416–418.CrossRefGoogle Scholar
  3. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269(18):2386–2391.PubMedCrossRefGoogle Scholar
  4. DeBellis R, Smith BS, Choi S, Malloy M. Management of delirium tremens. J Intensive Care Med 2005;20(3):164–173.PubMedCrossRefGoogle Scholar
  5. Engel GL, Romano J, Delirium A. Syndrome of Cerebral Insufficiency. J Chronic Dis 1959;9:260–277.PubMedCrossRefGoogle Scholar
  6. Harper C. The neuropathology of alcohol–specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol 1998;57:101–110.PubMedCrossRefGoogle Scholar
  7. Hollender MH. Pathological intoxication—is there such an entity? J Clin Psychiatry 1979;40(10):424–426.PubMedGoogle Scholar
  8. Hsiung GY, Sadovnick AD, Feldman H. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. Can Med Assoc J 2004;171(8):863–867.CrossRefGoogle Scholar
  9. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5H-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702–705.PubMedCrossRefGoogle Scholar
  10. Mayo-Smith MF, Beecher LH, Fischer TL, et al. Working Group on the Management of Alcohol Withdrawal Delirium, Practice Guidelines Committee, American Society of Addiction Medicine. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 2004;164(13):1405–1412. [Erratum in Arch Intern Med 2004;164(18):206.].PubMedCrossRefGoogle Scholar
  11. Myrick H, Malcolm R, Brady KT. Gabapentin treatment of alcohol withdrawal [letter]. Am J Psychiatry 1998;155:1632.PubMedGoogle Scholar


  1. Forman MS, Lee VM, Trojanowski JQ. Nosology of Parkinson’s disease: looking for the way out of a quagmire. Neuron 2005;47(4):479–482.PubMedCrossRefGoogle Scholar
  2. Heinrichs RW. The primacy of cognition in schizophrenia. Am Psychol 2005;60(3):229–242.PubMedCrossRefGoogle Scholar
  3. Hillbom M, Pieninkeroinen I, Leone M. Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs 2003;17(14):1013–1030.PubMedCrossRefGoogle Scholar
  4. Hulstaert F, Blennow K, Ivanoiu A, et al. Improved discrimination of AD patients using amyloid(1–42) and tau levels in CSF. Neurology 1999;52:1555.PubMedGoogle Scholar
  5. Mayeux R, Saunders A, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer’s disease. N Engl J Med 1998;338:506.PubMedCrossRefGoogle Scholar
  6. Ravaglia G. Incidence and etiology of dementia in a large elderly Italian population. Neurology 2005;64(9):1525–1530.PubMedCrossRefGoogle Scholar
  7. Reichenberg A. Cognitive impairment as a risk factor for psychosis. Dialogues Clin Neurosci 2005;7(1):31–38.PubMedGoogle Scholar
  8. Soyka M. Psychopathological characteristics in alcohol hallucinosis and paranoid schizophrenia. Acta Psychiatr Scand 1990;81(3):255–259.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Hoyle Leigh
    • 1
  1. 1.University of CaliforniaFresnoUSA

Personalised recommendations